The results of OurPath’s trial for diabetes patients from North West London are in.
Diabetes has fully emerged as a public health crisis – where according to a recent analysis by Diabetes UK has demonstrated that the number of adults and teenagers with diabetes has more than doubled in the last 20 years.
Already, the NHS spends £1.2 million per hour on diabetes care alone. In light of this, OurPath has partnered with practitioners to tackle the epidemic and help save the NHS.
In 2017, OurPath collaborated with Imperial College Health Partners (ICHP) and six NHS North West London Clinical Commissioning Groups (CCGs) to trial its platform to hundreds of patients across the capital. OurPath was one of three digital health providers to take part in the trials where a total of 18 GP practices participated.
The results were as follows for OurPath, according to the evaluation report published by ICHP:
Participant feedback from OurPath focus groups within the trial offered insights into their experience:
More information about the OurPath programme can be found here.
Across all three digital health platforms patients on the trial saw:
Along with the results – Dr. Tony Willis, the diabetes Clinical Lead for the North West London Collaboration of CCGs added praised the platforms:
“The results have been beyond our expectations. Historically, the education classes on offer for patients with Type 2 diabetes have seen low attendance. There was an excellent uptake of patients completing the trial using the apps. This alongside the clinically significant improvements in HbA1c, blood pressure and weight; show just how well people respond when they can receive support at the click of a button.”
You can find the original press release here.